Sherri Biondi, PhD AstraZeneca

Sherri joined AstraZeneca in March 2018 and as Head of Device Development. She is responsible for parenteral drug delivery devices including early stage technology selection, development and late stage scale-up for commercial manufacturing. Currently, her group is developing products such as prefilled syringes, autoinjectors, on-body delivery systems, and pen injectors as well as a range of other new technologies to meet the AstraZeneca pipeline needs. Prior to working at Astra Zeneca, Sherri was Director of Device Development at Genentech and Director of Product Development at Alexza Pharmaceuticals developing both injection and inhalation products.